Henry A. Nasrallah , MD

DR. HENRY NASRALLAH is an internationally recognized psychiatrist, educator and researcher. He received his BS and MD degrees at the American University of Beirut (AUB). Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as a faculty member at the University of California at San Diego and the University of Iowa before assuming the chair of the Ohio State University Department of Psychiatry for twelve years. In 2003, following a research sabbatical, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience and retired as Emeritus Professor in 2013 to go to Saint Louis University where he served as the Sydney W. Souers Endowed Chair of Neurology and Psychiatry for 6 years. He returned to UC in 2019 and rejoined the faculty full-time as Professor of Psychiatry, Neurology and Neuroscience.

Dr. Nasrallah currently serves as the Director of the Schizophrenia and Neuropsychiatry Programs. His research focuses on the neurobiology and psychopharmacology of schizophrenia and other psychotic disorders. He has published over 450 scientific articles, 600 abstracts, 170 editorials, as well as 13 books. He is the Editor of 3 journals prominent journals (Schizophrenia Research, Biomarkers in Neuropsychiatry and Current Psychiatry) and is co-founder of the Schizophrenia International Research Society (SIRS). He has been board-certified in both adult and geriatric psychiatry. He is a Fellow of the American College of Neuropsychopharmacology [ACNP], Fellow of the American College of Psychiatrists,  distinguished life Fellow of the American Psychiatric Association, and past President of the Cincinnati Psychiatric Society and the American Academy of Clinical Psychiatrists, past President of the Ohio Psychiatric Physicians Education and Research Foundation and past President of the University of Cincinnati College of Medicine Faculty [comprised of 1500  faculty members]. During his tenure at Saint Louis University, he was elected by all the state psychiatrists as President of the Missouri Psychiatric Physicians Association. He has twice received the NAMI Exemplary Psychiatrist Award and was recognized as the U.S. Teacher of the Year by The Psychiatric Times.  He has received over 95 federal, industry, and foundation research grants and has been elected annually to the list of Best Doctors in America for the past 25 years.
Henry A. Nasrallah, M.D.

Medical Degree: American University of Beirut

Residency: University of Rochester (Psychiatry)

Fellowship: National Institutes of Health (Neuroscience)

American Board of Psychiatry and Neurology (Psychiatry) (Certification Date: 04-30-1977 )

Bipolar Disorder

Mood Disorders

Psychiatry

Major Depressive Disorder

Psychotic Disorders

Schizophrenia

Geriatric Psychiatry

Psychiatry

Dr. Nasrallah's research focus is on the neurobiology and psychopharmacology of schizophrenia and related disorders.

Grant: #5-38111 / N01-MH90001 Investigators:Nasrallah, Henry 02-21-2003 -03-31-2010 National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness - CATIE Role:PI $279,826.00 Closed Level:Federal

Grant: #5-R01-MH-059312-03 Investigators:Nasrallah, Henry 05-01-2005 -04-30-2009 National Institute of Mental Health Effectiveness of Switching Antipsychotic Medications Role:PI $79,125.00 Active Level:Federal

Grant: #SRS 005227 Investigators:Nasrallah, Amelia; Nasrallah, Henry 03-01-2007 -02-28-2009 Foundation for the National Institutes of Health University of North Carolina at Chapel Hill Master Agreement - Camp Study Role:PI $10,450.00 Active Level:Private Non-Profit

Grant: #IRUSQUET0467 Investigators:Genter, Mary Beth; Nasrallah, Henry; Pixley, Sarah 07-15-2008 -11-14-2010 AstraZeneca, PLC. (United Kingdom) Beyond Dopamine and Serotonin: Regulation of Neurotophins, Neurogenesis, and Neuroplasticity by Quietiapine/Norquetiapine as a Marker of Antidepressa Role:Collaborator $119,960.00 Active Level:Foreign Industry

Grant: #SRS 005851 Investigators:Genter, Mary Beth; Nasrallah, Henry; Shertzer, Howard 09-15-2008 -09-14-2011 National Alliance for Research on Schizophrenia and Depression Acetaminophen vs. Metformin and Rosiglitazone: Can an OTC Replace Prescription Drugs in the Reversal of Antipsychotic Drug-Induced Metabolic Complicat Role:Collaborator $100,000.00 Closed Level:Private Non-Profit

Grant: #SRS 006212 Investigators:Chu, Wen-Jang; Eliassen, James; Krikorian, Robert; Nasrallah, Henry 07-06-2009 -06-30-2014 U.S. Highbush Blueberry Council Blueberry Supplementation, Inflammation, and Metabolism in Cognitive Aging Role:Collaborator $221,613.00 Active Level:Other

Grant: #R01 AG034617- Investigators:Fleck, David; Krikorian, Robert; McNamara, Robert; Nasrallah, Henry; Welge, Jeffrey 09-30-2009 -08-31-2014 National Institute on Aging Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline Role:Collaborator $1,331,722.00 Active Level:Federal

Grant: #K25 MH085103 Investigators:Adler, Caleb; Chu, Wen-Jang; Eliassen, James; Lee, Jing-Huei; Nasrallah, Henry; Nelson, Erik; Strakowski, Stephen 04-01-2010 -12-31-2013 National Institute of Mental Health Contrasting Glutamatergic Neurotransmission in Bipolar Disorder and Schizophrenia Role:Collaborator $495,850.00 Active Level:Federal

Peer Reviewed Publications

Nasrallah, Henry A; Hopkins, Tracy; Pixley, Sarah K (2010. ) Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats.Brain research, , 1354 ,23-9 More Information

Nasrallah, Henry A; Gopal, Srihari; Gassmann-Mayer, Cristiana; Quiroz, Jorge A; Lim, Pilar; Eerdekens, Mariëlle; Yuen, Eric; Hough, David (2010. ) A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, , 35 (10 ) ,2072-82 More Information

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S (2010. ) Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future.Schizophrenia research, , 122 (1-3 ) ,1-23 More Information

Shertzer, H G; Kendig, E L; Nasrallah, H A; Johansson, E; Genter, M B (2010. ) Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole.International journal of obesity (2005), , 34 (6 ) ,970-9 More Information

Meyer, Jonathan M; McEvoy, Joseph P; Davis, Vicki G; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Hsiao, John K; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A (2009. ) Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.Biological psychiatry, , 66 (11 ) ,1013-22 More Information

Danielyan, Arman; Nasrallah, Henry A (2009. ) Neurological disorders in schizophrenia.The Psychiatric clinics of North America, , 32 (4 ) ,719-57 More Information

Hwang, Michael Y; Nasrallah, Henry A (2009. ) Psychiatric and physical comorbidity in schizophrenia. Preface.The Psychiatric clinics of North America, , 32 (4 ) ,xiii-xv More Information

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S (2009. ) Schizophrenia, "just the facts" 4. Clinical features and conceptualization.Schizophrenia research, , 110 (1-3 ) ,1-23 More Information

Wiener, H W; Klei, L; Irvin, M D; Perry, R T; Aliyu, M H; Allen, T B; Bradford, L D; Calkins, M E; Devlin, B; Edwards, N; Gur, R E; Gur, R C; Kwentus, J; Lyons, P D; McEvoy, J P; Nasrallah, H A; Nimgaonkar, V L; O'Jile, J; Santos, A B; Savage, R M; Go, R C P (2009. ) Linkage analysis of schizophrenia in African-American families.Schizophrenia research, , 109 (1-3 ) ,70-9 More Information

Nasrallah, Henry A (2009. ) Meta-analysis trends in schizophrenia over three decades.Schizophrenia research, , 108 (1-3 ) ,1-2 More Information

Nasrallah, Henry A; Keshavan, Matcheri S; Benes, Francine M; Braff, David L; Green, Alan I; Gur, Raquel E; Kane, John M; Perkins, Diana O; Weiden, Peter J; Weinberger, Daniel R; Correll, Christoph U (2009. ) Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia. The Journal of clinical psychiatry, , 70 Suppl 1 ,4-46

Keshavan, Matcheri S; Tandon, Rajiv; Boutros, Nash N; Nasrallah, Henry A (2008. ) Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology.Schizophrenia research, , 106 (2-3 ) ,89-107 More Information

Devulapalli, Kavi K; Welge, Jeffrey A; Nasrallah, Henry A (2008. ) Temporal sequence of clinical manifestation in schizophrenia with co-morbid OCD: review and meta-analysis.Psychiatry research, , 161 (1 ) ,105-8 More Information

Daumit, Gail L; Goff, Donald C; Meyer, Jonathan M; Davis, Vicki G; Nasrallah, Henry A; McEvoy, Joseph P; Rosenheck, Robert; Davis, Sonia M; Hsiao, John K; Stroup, T Scott; Lieberman, Jeffrey A (2008. ) Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.Schizophrenia research, , 105 (1-3 ) ,175-87 More Information

Meyer, Jonathan M; Davis, Vicki G; McEvoy, Joseph P; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Daumit, Gail L; Hsiao, John; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A (2008. ) Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.Schizophrenia research, , 103 (1-3 ) ,104-9 More Information

Tandon, Rajiv; Keshavan, Matcheri S; Nasrallah, Henry A (2008. ) Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.Schizophrenia research, , 102 (1-3 ) ,1-18 More Information

Newcomer, John W; Nasrallah, Henry A; McIntyre, Roger S; McIntyre, Roger S; Vogel-Scibilia, Suzanne (2008. ) Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. Conclusion: summary and recommendations. CNS spectrums, , 13 (6 Suppl 10 ) ,13-4

Nasrallah, Henry A (2008. ) The urgent need for monitoring and intervention to reduce metabolic risk factors in patients with schizophrenia. CNS spectrums, , 13 (6 Suppl 10 ) ,5-6

Ali-Shtayeh, Mohammed S; Jamous, Rana M; Al-Shafie', Jehan H; Elgharabah, Wafa' A; Kherfan, Fatemah A; Qarariah, Kifayeh H; Khdair, Isra' S; Soos, Israa M; Musleh, Aseel A; Isa, Buthainah A; Herzallah, Hanan M; Khlaif, Rasha B; Aiash, Samiah M; Swaiti, Ghadah M; Abuzahra, Muna A; Haj-Ali, Maha M; Saifi, Nehaya A; Azem, Hebah K; Nasrallah, Hanadi A (2008. ) Traditional knowledge of wild edible plants used in Palestine (Northern West Bank): a comparative study.Journal of ethnobiology and ethnomedicine, , 4 ,13 More Information

Meyer, Jonathan M; Davis, Vicki G; Goff, Donald C; McEvoy, Joseph P; Nasrallah, Henry A; Davis, Sonia M; Rosenheck, Robert A; Daumit, Gail L; Hsiao, John; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A (2008. ) Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.Schizophrenia research, , 101 (1-3 ) ,273-86 More Information

Tandon, Rajiv; Keshavan, Matcheri S; Nasrallah, Henry A (2008. ) Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview.Schizophrenia research, , 100 (1-3 ) ,4-19 More Information

DeLisi, Lynn E; Nasrallah, Henry A (2008. ) Celebrating twenty years of schizophrenia research.Schizophrenia research, , 100 (1-3 ) ,1-3 More Information

Nasrallah, Henry A; Black, Donald W; Goldberg, Joseph F; Muzina, David J; Pariser, Stephen F (2008. ) Diagnosing and managing psychotic and mood disorders.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 20 Suppl 1 ,S1-28; quiz S29-30 More Information

Nasrallah, H A (2008. ) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.Molecular psychiatry, , 13 (1 ) ,27-35 More Information

Cerullo, Michael A; Adler, Caleb M; Strakowski, Stephen M; Eliassen, James C; Nasrallah, Henry A; Nasrallah, Amelia T (2007. ) Memantine normalizes brain activity in the inferior frontal gyrus: a controlled pilot fMRI study.Schizophrenia research, , 97 (1-3 ) ,294-6 More Information

Dlugosz, Heather; Nasrallah, Henry A (2007. ) Paliperidone: a new extended-release oral atypical antipsychotic.Expert opinion on pharmacotherapy, , 8 (14 ) ,2307-13 More Information

Glick, Ira D; Salzman, Carl; Cohen, Bruce M; Klein, Donald F; Moutier, Christine; Nasrallah, Henry A; Ongur, Dost; Wang, Po; Zisook, Sidney Improving the pedagogy associated with the teaching of psychopharmacology.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, , 31 (3 ) ,211-7 More Information

Nasrallah, H A (2007. ) The case for long-acting antipsychotic agents in the post-CATIE era.Acta psychiatrica Scandinavica, , 115 (4 ) ,260-7 More Information

Nasrallah, Henry A (2007. ) The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial. The Journal of clinical psychiatry, , 68 Suppl 1 ,5-11

Nasrallah, Henry A (2007. ) Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond. The Journal of clinical psychiatry, , 68 Suppl 1 ,3-4

Tandon, Rajiv; Targum, Steven D; Nasrallah, Henry A; Ross, Ruth (2006. ) Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. Journal of psychiatric practice, , 12 (6 ) ,348-63

Nasrallah, Henry A; Lasser, Rob (2006. ) Improving patient outcomes in schizophrenia: achieving remission.Journal of psychopharmacology (Oxford, England), , 20 (6 Suppl ) ,57-61 More Information

Nasrallah, Henry A; Dursun, Serdar M (2006. ) Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy.Journal of psychopharmacology (Oxford, England), , 20 (6 Suppl ) ,3-5 More Information

Nasrallah, Henry A; Brecher, Martin; Paulsson, Björn (2006. ) Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.Bipolar disorders, , 8 (5 Pt 1 ) ,467-74 More Information

Nasrallah, Henry A; Ketter, Terence A; Kalali, Amir H (2006. ) Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.Journal of affective disorders, , 95 (1-3 ) ,69-78 More Information

Nasrallah, Henry A; Meyer, Jonathan M; Goff, Donald C; McEvoy, Joseph P; Davis, Sonia M; Stroup, T Scott; Lieberman, Jeffrey A (2006. ) Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.Schizophrenia research, , 86 (1-3 ) ,15-22 More Information

Tandon, Rajiv; Nasrallah, Henry A (2006. ) Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses.Archives of general psychiatry, , 63 (8 ) ,935-7; author reply More Information

Terry, Alvin V; Parikh, Vinay; Gearhart, Debra A; Pillai, Anilkumar; Hohnadel, Elizabeth; Warner, Samantha; Nasrallah, Henry A; Mahadik, Sahebarao P (2006. ) Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats.The Journal of pharmacology and experimental therapeutics, , 318 (2 ) ,709-24 More Information

Ramaswamy, Krishnan; Masand, Prakash S; Nasrallah, Henry A Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 18 (3 ) ,183-94 More Information

Nasrallah, Henry A (2006. ) Metabolic findings from the CATIE trial and their relation to tolerability. CNS spectrums, , 11 (7 Suppl 7 ) ,32-9

Singh, Manpreet K; Giles, Lisa L; Nasrallah, Henry A (2006. ) Pain insensitivity in schizophrenia: trait or state marker? .Journal of psychiatric practice, , 12 (2 ) ,90-102

Nasrallah, Henry A Focus on lower risk of tardive dyskinesia with atypical antipsychotics.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 18 (1 ) ,57-62 More Information

Gianfrancesco, Frank; Wang, Ruey-Hua; Nasrallah, Henry A The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 18 (1 ) ,9-17 More Information

Ketter, Terence A; Nasrallah, Henry A; Fagiolini, Andrea (2006. ) Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Psychopharmacology bulletin, , 39 (1 ) ,120-46

Delisi, L E; Nasrallah, H A (2005. ) The CATIE schizophrenia effectiveness trial.Schizophrenia research, , 80 (1 ) ,v-vi More Information

Goff, Donald C; Sullivan, Lisa M; McEvoy, Joseph P; Meyer, Jonathan M; Nasrallah, Henry A; Daumit, Gail L; Lamberti, Steven; D'Agostino, Ralph B; Stroup, Thomas S; Davis, Sonia; Lieberman, Jeffrey A (2005. ) A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls.Schizophrenia research, , 80 (1 ) ,45-53 More Information

McEvoy, Joseph P; Meyer, Jonathan M; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Sullivan, Lisa; Meltzer, Herbert Y; Hsiao, John; Scott Stroup, T; Lieberman, Jeffrey A (2005. ) Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.Schizophrenia research, , 80 (1 ) ,19-32 More Information

Meyer, Jonathan M; Nasrallah, Henry A; McEvoy, Joseph P; Goff, Donald C; Davis, Sonia M; Chakos, Miranda; Patel, Jayendra K; Keefe, Richard S E; Stroup, T Scott; Lieberman, Jeffrey A (2005. ) The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.Schizophrenia research, , 80 (1 ) ,9-18 More Information

Nasrallah, Henry A; Targum, Steven D; Tandon, Rajiv; McCombs, Jeffrey S; Ross, Ruth (2005. ) Defining and measuring clinical effectiveness in the treatment of schizophrenia.Psychiatric services (Washington, D.C.), , 56 (3 ) ,273-82 More Information

Nasrallah, Henry A (2005. ) Neurologic comorbidities in schizophrenia. The Journal of clinical psychiatry, , 66 Suppl 6 ,34-46

Nasrallah, Henry A (2005. ) An overview of common medical comorbidities in patients with schizophrenia. The Journal of clinical psychiatry, , 66 Suppl 6 ,3-4

Lasser, Robert; Bossie, Cynthia A; Gharabawi, Georges; Eerdekens, Marielle; Nasrallah, Henry A (2004. ) Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder.Journal of affective disorders, , 83 (2-3 ) ,263-75 More Information

Nasrallah, Henry A; Newcomer, John W (2004. ) Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. Journal of clinical psychopharmacology, , 24 (5 Suppl 1 ) ,S7-14

Newcomer, John W; Nasrallah, Henry A; Loebel, Antony D (2004. ) The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists. Journal of clinical psychopharmacology, , 24 (5 Suppl 1 ) ,S1-6

Nasrallah, Henry A; White, Thantween; Nasrallah, Amelia T Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: preliminary analysis of retrospective data.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, , 12 (4 ) ,437-9 More Information

Menon, P Mohanakrishnan; Nasrallah, Henry A; Reeves, Roy R; Ali, Jeffrey A (2004. ) Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study.Brain research, , 1009 (1-2 ) ,189-94 More Information

Mittal, Dinesh; Jimerson, Nita A; Neely, Emily P; Johnson, William D; Kennedy, Richard E; Torres, Rafael A; Nasrallah, Henry A (2004. ) Risperidone in the treatment of delirium: results from a prospective open-label trial. The Journal of clinical psychiatry, , 65 (5 ) ,662-7

Nasrallah, Henry A; Duchesne, Inge; Mehnert, Angelika; Janagap, Carmela; Eerdekens, Mariëlle (2004. ) Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. The Journal of clinical psychiatry, , 65 (4 ) ,531-6

Keith, Samuel J; Kane, John M; Turner, Martin; Conley, Robert R; Nasrallah, Henry A (2004. ) Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics. The Journal of clinical psychiatry, , 65 (1 ) ,120-31

Jeste, Dilip V; Nasrallah, Henry A Schizophrenia and aging: no more dearth of data? .The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, , 11 (6 ) ,584-7

Nasrallah, Henry A (2003. ) Factors in antipsychotic drug selection: tolerability considerations. CNS spectrums, , 8 (11 Suppl 2 ) ,23-5

Gianfrancesco, Frank; White, Richard; Wang, Ruey-hua; Nasrallah, Henry A (2003. ) Antipsychotic-induced type 2 diabetes: evidence from a large health plan database.Journal of clinical psychopharmacology, , 23 (4 ) ,328-35 More Information

Mohanakrishnan Menon, P; Nasrallah, Henry A; Lyons, Judith A; Scott, Mertis F; Liberto, Vincent (2003. ) Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry research, , 123 (2 ) ,101-8

Nasrallah, Hassan A; Balling, Robert C; Madi, Shaker Mohammed; Al-Ansari, Lamya (2003. ) Temporal variations in atmospheric CO2 concentrations in Kuwait City, Kuwait with comparisons to Phoenix, Arizona, USA. Environmental pollution (Barking, Essex : 1987), , 121 (2 ) ,301-5

Möller, Hans-Jürgen; Nasrallah, Henry A (2003. ) Treatment of bipolar disorder. The Journal of clinical psychiatry, , 64 Suppl 6 ,9-17; discussion 28

Nasrallah, Henry A (2002. ) Pharmacoeconomic implications of adverse effects during antipsychotic drug therapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 59 (22 Suppl 8 ) ,S16-21

Gianfrancesco, Frank D; Grogg, Amy L; Mahmoud, Ramy A; Wang, Ruey-hua; Nasrallah, Henry A (2002. ) Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. The Journal of clinical psychiatry, , 63 (10 ) ,920-30

Nasrallah, Henry A; Tandon, Rajiv (2002. ) Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia. The Journal of clinical psychiatry, , 63 Suppl 13 ,12-20

Nasrallah, H A; Mulvihill, T (2001. ) Iatrogenic disorders associated with conventional vs. atypical antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 13 (4 ) ,215-27

Niedermier, J A; Nasrallah, H A (1998. ) Clinical correlates of response to valproate in geriatric inpatients. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 10 (4 ) ,165-8

Basso, M R; Nasrallah, H A; Olson, S C; Bornstein, R A (1998. ) Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia research, , 31 (2-3 ) ,99-111

Nasrallah, H A; Sharma, S; Olson, S C (1997. ) The volume of the entorhinal cortex in schizophrenia: a controlled MRI study. Progress in neuro-psychopharmacology & biological psychiatry, , 21 (8 ) ,1317-22

Nasrallah, H A; Tolbert, H A (1997. ) Neurobiology and neuroplasticity in schizophrenia. Continuity across the life cycle. Archives of general psychiatry, , 54 (10 ) ,913-4

Pariser, S F; Nasrallah, H A; Gardner, D K (1997. ) Postpartum mood disorders: clinical perspectives. Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research, , 6 (4 ) ,421-34

Basso, M R; Nasrallah, H A; Olson, S C; Bornstein, R A (1997. ) Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry, neuropsychology, and behavioral neurology, , 10 (2 ) ,107-12

Boutros, N N; Torello, M W; Barker, B A; Tueting, P A; Wu, S C; Nasrallah, H A (1995. ) The P50 evoked potential component and mismatch detection in normal volunteers: implications for the study of sensory gating. Psychiatry research, , 57 (1 ) ,83-8

Boutros, N; Torello, M W; Burns, E M; Wu, S S; Nasrallah, H A (1995. ) Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry research, , 57 (1 ) ,57-63

Nasrallah, H A (1995. ) Brain and CSF volume differences in schizophrenic subtypes. The American journal of psychiatry, , 152 (5 ) ,817; author reply 81

Nasrallah, H A; Skinner, T E; Schmalbrock, P; Robitaille, P M (1994. ) Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. The British journal of psychiatry : the journal of mental science, , 165 (4 ) ,481-5

Podraza, A M; Bornstein, R A; Whitacre, C C; Para, M F; Fass, R J; Rice, R R; Nasrallah, H A (1994. ) Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. Journal of clinical and experimental neuropsychology, , 16 (5 ) ,777-83

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J (1994. ) Duration of illness and neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, , 6 (2 ) ,160-4

Beason-Hazen, S; Nasrallah, H A; Bornstein, R A (1994. ) Self-report of symptoms and neuropsychological performance in asymptomatic HIV-positive individuals. The Journal of neuropsychiatry and clinical neurosciences, , 6 (1 ) ,43-9

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J (1993. ) Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS (London, England), , 7 (12 ) ,1607-11

Jurjus, G J; Nasrallah, H A; Brogan, M; Olson, S C (1993. ) Developmental brain anomalies in schizophrenia and bipolar disorder: a controlled MRI study. The Journal of neuropsychiatry and clinical neurosciences, , 5 (4 ) ,375-8

Bornstein, R A; Fama, R; Rosenberger, P; Whitacre, C C; Para, M F; Nasrallah, H A; Fass, R J (1993. ) Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, , 5 (3 ) ,254-9

Bornstein, R A; Pace, P; Rosenberger, P; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J (1993. ) Depression and neuropsychological performance in asymptomatic HIV infection. The American journal of psychiatry, , 150 (6 ) ,922-7

Nasrallah, H A (1993. ) Neurodevelopmental pathogenesis of schizophrenia. The Psychiatric clinics of North America, , 16 (2 ) ,269-80

Rosenberger, P H; Bornstein, R A; Nasrallah, H A; Para, M F; Whitaker, C C; Fass, R J; Rice, R R Psychopathology in human immunodeficiency virus infection: lifetime and current assessment. Comprehensive psychiatry, , 34 (3 ) ,150-8

Jurjus, G J; Nasrallah, H A; Olson, S C; Schwarzkopf, S B (1993. ) Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study. Psychological medicine, , 23 (2 ) ,319-22

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Rosenberger, P; Fass, R J (1993. ) Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS (London, England), , 7 (4 ) ,519-24

McCoy, L; Votolato, N A; Schwarzkopf, S B; Nasrallah, H A (1993. ) Clinical correlates of valproate augmentation in refractory bipolar disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 5 (1 ) ,29-33

Olson, S C; Bornstein, R A; Schwarzkopf, S B; Nasrallah, H A (1993. ) Are controls in schizophrenia research "normal"? .Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 5 (1 ) ,1-5

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Rosenberger, P; Fass, R J; Rice, R (1992. ) Neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, , 4 (4 ) ,386-94

Bornstein, R A; Schwarzkopf, S B; Olson, S C; Nasrallah, H A (1992. ) Third-ventricle enlargement and neuropsychological deficit in schizophrenia. Biological psychiatry, , 31 (9 ) ,954-61

Bornstein, R A; Chakeres, D; Brogan, M; Nasrallah, H A; Fass, R J; Para, M; Whitacre, C (1992. ) Magnetic resonance imaging of white matter lesions in HIV infection. The Journal of neuropsychiatry and clinical neurosciences, , 4 (2 ) ,174-8

Nasrallah, H A (1991. ) Progressive and static ventriculomegaly in schizophrenia: clinical and methodological variables. Schizophrenia research, , 5 (3 ) ,191-2

Bornstein, R A; Nasrallah, H A; Para, M F; Fass, R J; Whitacre, C C; Rice, R R (1991. ) Rate of CD4 decline and neuropsychological performance in HIV infection. Archives of neurology, , 48 (7 ) ,704-7

Schwarzkopf, S B; Nasrallah, H A; Olson, S C; Bogerts, B; McLaughlin, J A; Mitra, T (1991. ) Family history and brain morphology in schizophrenia: an MRI study. Psychiatry research, , 40 (1 ) ,49-60

Nasrallah, H A; Schwarzkopf, S B; Olson, S C; Coffman, J A (1991. ) Perinatal brain injury and cerebellar vermal lobules I-X in schizophrenia. Biological psychiatry, , 29 (6 ) ,567-74

Nasrallah, H A (1991. ) Neurodevelopmental aspects of bipolar affective disorder. Biological psychiatry, , 29 (1 ) ,1-2

Coffman, J A; Torello, M W; Bornstein, R A; Chakeres, D; Burns, E; Nasrallah, H A (1990. ) Leukoaraiosis in asymptomatic adult offspring of individuals with Alzheimer's disease. Biological psychiatry, , 27 (11 ) ,1244-8

Coffman, J A; Bornstein, R A; Olson, S C; Schwarzkopf, S B; Nasrallah, H A (1990. ) Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biological psychiatry, , 27 (11 ) ,1188-96

Schwarzkopf, S B; Lamberti, J S; Jiminez, M; Kane, C F; Henricks, M; Nasrallah, H A (1990. ) Visual evoked potential correlates of positive/negative symptoms in schizophrenia. Biological psychiatry, , 27 (4 ) ,400-10

Paulman, R G; Devous, M D; Gregory, R R; Herman, J H; Jennings, L; Bonte, F J; Nasrallah, H A; Raese, J D (1990. ) Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biological psychiatry, , 27 (4 ) ,377-99

Bornstein, R A; Nasrallah, H A; Olson, S C; Coffman, J A; Torello, M; Schwarzkopf, S B (1990. ) Neuropsychological deficit in schizophrenic subtypes: paranoid, nonparanoid, and schizoaffective subgroups. Psychiatry research, , 31 (1 ) ,15-24

Schwarzkopf, S B; Olson, S C; Coffman, J A; Nasrallah, H A (1990. ) Third and lateral ventricular volumes in schizophrenia: support for progressive enlargement of both structures. Psychopharmacology bulletin, , 26 (3 ) ,385-91

Nasrallah, H A; Schwarzkopf, S B; Olson, S C; Coffman, J A (1990. ) Gender differences in schizophrenia on MRI brain scans. Schizophrenia bulletin, , 16 (2 ) ,205-10

Nasrallah, H A (1989. ) Right-hemisphere speech, callosal size, perinatal brain insult, and schizophrenia.Annals of neurology, , 26 (2 ) ,290-1 More Information

Coffman, J A; Schwarzkopf, S B; Olson, S C; Nasrallah, H A Midsagittal cerebral anatomy by magnetic resonance imaging. The importance of slice position and thickness. Schizophrenia research, , 2 (3 ) ,287-94

Schwarzkopf, S B; Nasrallah, H A; Olson, S C; Coffman, J A; McLaughlin, J A (1989. ) Perinatal complications and genetic loading in schizophrenia: preliminary findings. Psychiatry research, , 27 (3 ) ,233-9

Nasrallah, H A; Coffman, J A; Olson, S C (1989. ) Structural brain-imaging findings in affective disorders: an overview. The Journal of neuropsychiatry and clinical neurosciences, , 1 (1 ) ,21-6

Nasrallah, H A; Churchill, C M; Hamdan-Allan, G A (1988. ) Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. The American journal of psychiatry, , 145 (11 ) ,1455-6

Schwarzkopf, S B; Chapman, R M; Jimenez, M; Treglia, L; Kane, C F; Lamberti, J S; Nasrallah, H A (1988. ) Familial and sporadic schizophrenia: visual evoked potential differences. Biological psychiatry, , 24 (7 ) ,828-33

Burns, E M; Nasrallah, H A; Kathol, M H; Kruckeberg, T W; Coffman, J A (1987. ) Right vs. left hemispheric blood-brain barrier permeability in schizophrenia: a dynamic computed tomographic study. Psychiatry research, , 22 (3 ) ,229-41

Wilcox, J A; Nasrallah, H A (1987. ) Childhood head trauma and psychosis. Psychiatry research, , 21 (4 ) ,303-6

Coffman, J A; Nasrallah, H A; Olson, S C (1987. ) Differences between schizophrenics and controls in CT-measured radiodensity of samples from the anterior corpus callosum. Acta psychiatrica Scandinavica, , 75 (4 ) ,446

Coffman, J A; Nasrallah, H A; Lyskowski, J; McCalley-Whitters, M; Dunner, F J (1987. ) Clinical effectiveness of oral and parenteral rapid neuroleptization. The Journal of clinical psychiatry, , 48 (1 ) ,20-4

Wilcox, J A; Nasrallah, H A (1987. ) Perinatal distress and prognosis of psychotic illness. Neuropsychobiology, , 17 (4 ) ,173-5

Wilcox, J A; Nasrallah, H A (1987. ) Perinatal insult as a risk factor in paranoid and nonparanoid schizophrenia. Psychopathology, , 20 (5-6 ) ,285-7

Wilcox, J A; Nasrallah, H A (1986. ) Organic factors in catatonia. The British journal of psychiatry : the journal of mental science, , 149 ,782-4

Nasrallah, H A; Varney, N; Coffman, J A; Bayless, J; Chapman, S (1986. ) Opiate antagonism fails to reverse post-ECT cognitive deficits. The Journal of clinical psychiatry, , 47 (11 ) ,555-6

Lewis, D A; Nasrallah, H A (1986. ) Mania associated with electroconvulsive therapy. The Journal of clinical psychiatry, , 47 (7 ) ,366-7

Nasrallah, H A; Andreasen, N C; Coffman, J A; Olson, S C; Dunn, V D; Ehrhardt, J C; Chapman, S M (1986. ) A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia. Biological psychiatry, , 21 (3 ) ,274-82

D'Mello, D A; Nasrallah, H A (1986. ) Suppression of tardive dyskinesia with amoxapine: case report. The Journal of clinical psychiatry, , 47 (3 ) ,148

Nasrallah, H A; Loney, J; Olson, S C; McCalley-Whitters, M; Kramer, J; Jacoby, C G (1986. ) Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry research, , 17 (3 ) ,241-6

Nasrallah, H A; Olson, S C; McCalley-Whitters, M; Chapman, S; Jacoby, C G (1986. ) Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Archives of general psychiatry, , 43 (2 ) ,157-9

Andreasen, N; Nasrallah, H A; Dunn, V; Olson, S C; Grove, W M; Ehrhardt, J C; Coffman, J A; Crossett, J H (1986. ) Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Archives of general psychiatry, , 43 (2 ) ,136-44

Nasrallah, H A; Dunner, F J; McCalley-Whitters, M; Smith, R E (1986. ) Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. The Journal of clinical psychiatry, , 47 (2 ) ,56-9

Wilcox, J A; Nasrallah, H A (1986. ) Sydenham's chorea and psychosis. Neuropsychobiology, , 15 (1 ) ,13-4

Rogers, K L; Nasrallah, H A (1985. ) ECT was found to be effective in remitting the symptoms of late onset diabetes mellitus. Acta psychiatrica Scandinavica, , 72 (4 ) ,402

Kronfol, Z; Nasrallah, H A; Chapman, S; House, J D (1985. ) Depression, cortisol metabolism and lymphocytopenia. Journal of affective disorders, , 9 (2 ) ,169-73

Coffman, J A; Nasrallah, H A (1985. ) Relationships between brain density, cortical atrophy and ventriculomegaly in schizophrenia and mania. Acta psychiatrica Scandinavica, , 72 (2 ) ,126-32

Jaeckle, R S; Nasrallah, H A (1985. ) Major depression and carbon monoxide-induced parkinsonism: diagnosis, computerized axial tomography, and response to L-dopa. The Journal of nervous and mental disease, , 173 (8 ) ,503-8

Nasrallah, H A The unintegrated right cerebral hemispheric consciousness as alien intruder: a possible mechanism for Schneiderian delusions in schizophrenia. Comprehensive psychiatry, , 26 (3 ) ,273-82

Nasrallah, H A; Jacoby, C G; Chapman, S; McCalley-Whitters, M (1985. ) Third ventricular enlargement on CT scans in schizophrenia: association with cerebellar atrophy. Biological psychiatry, , 20 (4 ) ,443-50

Coffman, J A; Olshansky, B; Nasrallah, H A; Skorton, D; Chapman, S (1985. ) Echocardiographic assessment of schizophrenics and manics: a reexamination of early necropsy findings. The Journal of nervous and mental disease, , 173 (3 ) ,179-81

Nasrallah, H A; Dunner, F J; McCalley-Whitters, M (1985. ) A placebo-controlled trial of valproate in tardive dyskinesia. Biological psychiatry, , 20 (2 ) ,205-8

Nasrallah, H A; Varney, N; Coffman, J A; Bayless, J; Chapman, S (1985. ) Effects of naloxone on cognitive deficits following electroconvulsive therapy. Psychopharmacology bulletin, , 21 (1 ) ,89-90

Coffman, J A; Nasrallah, H A (1984. ) Statistical "noise" in CAT scan measurements. The American journal of psychiatry, , 141 (10 ) ,1311-2

Tsai, L Y; Nasrallah, H A; Jacoby, C G (1984. ) Cerebral asymmetry in subtypes of schizophrenia. The Journal of clinical psychiatry, , 45 (10 ) ,423-5

Nasrallah, H A; McCalley-Whitters, M; Pfohl, B (1984. ) Clinical significance of large cerebral ventricles in manic males. Psychiatry research, , 13 (2 ) ,151-6

Coffman, J A; Andreasen, N C; Nasrallah, H A (1984. ) Left hemispheric density deficits in chronic schizophrenia. Biological psychiatry, , 19 (8 ) ,1237-47

Nasrallah, H A; Dunner, F J; Smith, R E; McCalley-Whitters, M; Sherman, A D (1984. ) Variable clinical response to choline in tardive dyskinesia. Psychological medicine, , 14 (3 ) ,697-700

Nasrallah, H A; McCalley-Whitters, M; Chapman, S (1984. ) Cerebral ventricular enlargement and suicide in schizophrenia and mania. The American journal of psychiatry, , 141 (7 ) ,919

Coffman, J A; Nasrallah, H A (1984. ) Brain density patterns in schizophrenia and mania. Journal of affective disorders, , 6 (3-4 ) ,307-15

Nasrallah, H A; McCalley-Whitters, M (1984. ) Seasonality of birth in subtypes of chronic schizophrenia. Acta psychiatrica Scandinavica, , 69 (4 ) ,292-5

Wilson, R L; Waziri, R; Nasrallah, H A; McCalley-Whitters, M (1984. ) The lateralization of tardive dyskinesia. Biological psychiatry, , 19 (4 ) ,629-35

Tsai, L Y; Nasrallah, H A; Jacoby, C G (1983. ) Hemispheric asymmetries on computed tomographic scans in schizophrenia and mania. A controlled study and a critical review. Archives of general psychiatry, , 40 (12 ) ,1286-9

Alexander, B; Nasrallah, H A; Perry, P J; Liskow, B I; Dunner, F J (1983. ) The impact of psychopharmacology education on prescribing practices. Hospital & community psychiatry, , 34 (12 ) ,1150-3

Nasrallah, H A; Kuperman, S; Jacoby, C G; McCalley-Whitters, M; Hamra, B (1983. ) Clinical correlates of sulcal widening in chronic schizophrenia. Psychiatry research, , 10 (4 ) ,237-42

Nasrallah, H A; Kuperman, S; Hamra, B J; McCalley-Whitters, M (1983. ) Clinical differences between schizophrenic patients with and without large cerebral ventricles. The Journal of clinical psychiatry, , 44 (11 ) ,407-9

Nasrallah, H A; Keelor, K; McCalley-Whitters, M (1983. ) Laterality shift in alcoholic males. Biological psychiatry, , 18 (9 ) ,1065-7

Singh, M M; Becker, R E; Pitman, R K; Nasrallah, H A; Lal, H (1983. ) Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvement. Brain research bulletin, , 11 (2 ) ,179-85

Nasrallah, H A; McCalley-Whitters, M; Bigelow, L B; Rauscher, F P (1983. ) A histological study of the corpus callosum in chronic schizophrenia. Psychiatry research, , 8 (4 ) ,251-60

Hamra, B J; Nasrallah, H A; Clancy, J; Finn, R (1983. ) Psychiatric diagnosis and risk for tardive dyskinesia. Archives of general psychiatry, , 40 (3 ) ,346-7

Bigelow, L B; Nasrallah, H A; Rauscher, F P (1983. ) Corpus callosum thickness in chronic schizophrenia. The British journal of psychiatry : the journal of mental science, , 142 ,284-7

McCalley-Whitters, M; Nasrallah, H A (1983. ) Tardive dyskinesia in a phantom limb. The British journal of psychiatry : the journal of mental science, , 142 ,206-7

Nasrallah, H A; Tippin, J; McCalley-Whitters, M (1983. ) Neurological soft signs in manic patients. A comparison with Schizophrenic and control groups. Journal of affective disorders, , 5 (1 ) ,45-50

Schroeder, D; Nasrallah, H A (1982. ) High alcoholism rate in patients with essential tremor. The American journal of psychiatry, , 139 (11 ) ,1471-3

Nasrallah, H A; McCalley-Whitters, M; Jacoby, C G (1982. ) Cortical atrophy in schizophrenia and mania: a comparative CT study. The Journal of clinical psychiatry, , 43 (11 ) ,439-41

Nasrallah, H A; Tippin, J; McCalley-Whitters, M; Kuperman, S (1982. ) Neurological differences between paranoid and nonparanoid schizophrenia: part III. neurological soft signs. The Journal of clinical psychiatry, , 43 (8 ) ,310-2

Nasrallah, H A; Rizzo, M; Damasio, H; McCalley-Whitters, M; Kuperman, S; Jacoby, C G (1982. ) Neurological differences between paranoid and nonparanoid schizophrenia: part II. computerized tomographic findings. The Journal of clinical psychiatry, , 43 (8 ) ,307-9

Nasrallah, H A; McCalley-Whitters, M; Kuperman, S (1982. ) Neurological differences between paranoid and nonparanoid schizophrenia: part I. sensory-motor lateralization. The Journal of clinical psychiatry, , 43 (8 ) ,305-6

Nasrallah, H A; Jacoby, C G; McCalley-Whitters, M; Kuperman, S (1982. ) Cerebral ventricular enlargement in subtypes of chronic schizophrenia. Archives of general psychiatry, , 39 (7 ) ,774-7

Nasrallah, H A (1982. ) Neuropathology of the corpus callosum in schizophrenia. The British journal of psychiatry : the journal of mental science, , 141 ,99-100

Lyskowski, J; Nasrallah, H A; Dunner, F J; Bucher, K (1982. ) A longitudinal survey of side effects in a lithium clinic. The Journal of clinical psychiatry, , 43 (7 ) ,284-6

Singh, M M; Becker, R E; Pitman, R K; Nasrallah, H A; Lal, H; Dufresne, R L; Weber, S S; McCalley-Whitters, M (1982. ) Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model. Biological psychiatry, , 17 (6 ) ,729-42

Nasrallah, H A; McCalley-Whitters, M (1982. ) Motor lateralization in manic males. The British journal of psychiatry : the journal of mental science, , 140 ,521-2

Nasrallah, H A; Schroeder, D; Petty, F (1982. ) Alcoholism secondary to essential tremor. The Journal of clinical psychiatry, , 43 (4 ) ,163-4

Nasrallah, H A (1982. ) Hemispheric asymmetry in affective disorders. Psychopharmacology bulletin, , 18 (2 ) ,62-7

Nasrallah, H A; McCalley-Whitters, M; Jacoby, C G (1982. ) Cerebral ventricular enlargement in young manic males. A controlled CT study. Journal of affective disorders, , 4 (1 ) ,15-9

Nasrallah, H A; Lyskowksi, J; Schroeder, D (1982. ) TCA-induced mania: differences between switchers and nonswitchers. Biological psychiatry, , 17 (2 ) ,271-4

Nasrallah, H A; Coryell, W H (1982. ) Dexamethasone nonsuppression predicts the antidepressant effects of sleep deprivation. Psychiatry research, , 6 (1 ) ,61-64

Nasrallah, H A; Smith, R E; Dunner, F J; McCalley-Whitters, M (1982. ) Serotonin precursor effects in tardive dyskinesia. Psychopharmacology, , 77 (3 ) ,234-5

Petty, F; Nasrallah, H A Secondary depression in alcoholism: implications for future research. Comprehensive psychiatry, , 22 (6 ) ,587-95

Lyskowski, J; Nasrallah, H A (1981. ) Slowed release lithium: a review and a comparative study. Journal of clinical psychopharmacology, , 1 (6 ) ,406-8

Lyskowski, J; Nasrallah, H A (1981. ) Lithium therapy and the risk for leukemia. The British journal of psychiatry : the journal of mental science, , 139 ,256

Nasrallah, H A; Keelor, K; Van Schroeder, C; Whitters, M M (1981. ) Motoric lateralization in schizophrenic males. The American journal of psychiatry, , 138 (8 ) ,1114-5

Nasrallah, H A; McChesney, C M (1981. ) Psychopathology of corpus callosum tumors. Biological psychiatry, , 16 (7 ) ,663-9

Nasrallah, H A; Jacoby, C G; McCalley-Whitters, M (1981. ) Cerebellar atrophy in schizophrenia and mania. Lancet, , 1 (8229 ) ,1102

Nasrallah, H A; Fowler, R C; Judd, L L (1981. ) Schizophrenia-like illness following head injury. Psychosomatics, , 22 (4 ) ,359-61

Nasrallah, H A; Kleinman, J E; Weinberger, D R; Gillin, J C; Wyatt, R J (1980. ) Cerebral ventricular enlargement and dopamine synthesis inhibition in chronic schizophrenia. Archives of general psychiatry, , 37 (12 ) ,1427-

Nasrallah, H A; Kuperman, S; Coryell, W (1980. ) Reversal of dexamethasone nonsuppression with sleep deprivation in primary depression. The American journal of psychiatry, , 137 (11 ) ,1463-4

Smith, R E; Low, N N; Nasrallah, H A (1980. ) Haloperidol and an unrelated sudden death. The American journal of psychiatry, , 137 (7 ) ,843-4

Nasrallah, H A; Pappas, N J; Crowe, R R (1980. ) Oculogyric dystonia in tardive dyskinesia. The American journal of psychiatry, , 137 (7 ) ,850-1

Freed, W J; Nasrallah, H A; Rogol, A D; Wyatt, R J (1980. ) Propranolol in high doses increases plasma prolactin concentrations in male rats. Biological psychiatry, , 15 (2 ) ,311-7

Rauscher, F P; Nasrallah, H A; Wyatt, R J (1980. ) Cutaneous histamine response in schizophrenia. The Journal of clinical psychiatry, , 41 (2 ) ,44-51

Nasrallah, H A (1980. ) Neuroleptic plasma levels and tardive dyskinesia: a possible link? .Schizophrenia bulletin, , 6 (1 ) ,4-7

Kleinman, J E; Potkin, S; Rogol, A; Buchsbaum, M S; Murphy, D L; Gillin, J C; Nasrallah, H A; Wyatt, R J (1979. ) A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Science (New York, N.Y.), , 206 (4417 ) ,479-81

Nasrallah, H A (1979. ) Tardive dyskinesia symptoms. Psychopharmacology bulletin, , 15 (4 ) ,5-6

Nasrallah, H A; Holley, T; Janowsky, D S (1979. ) Opiate antagonism fails to reverse hypnotic-induced analgesia. Lancet, , 1 (8130 ) ,1355

Nasrallah, H A; Risch, S C; Fowler, R C (1979. ) Reserpine, serotonin, and schizophrenia. The American journal of psychiatry, , 136 (6 ) ,856-7

Nasrallah, H A (1979. ) Vulnerability to disulfiram psychosis. The Western journal of medicine, , 130 (6 ) ,575-7

Nasrallah, H A (1979. ) Tardive dyskinesia and depot fluphenazine. The British journal of psychiatry : the journal of mental science, , 134 ,550

Nasrallah, H A (1979. ) Methodological issues in tardive dyskinesia research. Schizophrenia bulletin, , 5 (1 ) ,1-2

Nasrallah, H A; Rivera-Calimlin, L; Rogol, A D (1978. ) Fluphenazine decanoate: plasma concentrations and clinical response [proceedings] .Psychopharmacology bulletin, , 14 (3 ) ,46-7

Donnelly, E F; Nasrallah, H A; Wyatt, R J; Gillin, J C; Bigelow, L B (1978. ) Effects of dopamine synthesis inhibition on WAIS comprehension. Journal of consulting and clinical psychology, , 46 (3 ) ,385-8

Carman, J S; Wyatt, R J; Nasrallah, H A; O'Brien, P; Gillin, J C (1978. ) Weight change during various neuropharmacologic manipulations in psychotic inpatients. Acta científica venezolana, , 29 (3 ) ,178-80

Nasrallah, H A (1978. ) Factors influencing phenothiazine-induced ECG changes. The American journal of psychiatry, , 135 (1 ) ,118-9

Potkin, S G; Gillin, J C; Rogol, A; Nasrallah, H A; Wyatt, R J (1978. ) Baclofen: lack of effect on human plasma prolactin. Communications in psychopharmacology, , 2 (4 ) ,297-300

Rivera-Calimlim, L; Gift, T; Nasrallah, H A; Wyatt, R J; Lasagna, L (1978. ) Correlation between plasma concentrations of chlorpromazine and clinical response. Communications in psychopharmacology, , 2 (3 ) ,215-22

Nasrallah, H A; Freed, W J; Rogol, A; Wyatt, R J (1977. ) Propranolol and prolactin. Lancet, , 2 (8049 ) ,1175-6

Nasrallah, H A; Donnelly, E F; Bigelow, L B; Rivera-Calimlim, L; Rogol, A; Potkin, S; Rauscher, F P; Wyatt, R J (1977. ) Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine. Archives of general psychiatry, , 34 (6 ) ,649-55

Nasrallah, Henry A; Weiden, Peter J; Walling, David P; Du, Yangchun; Yao, Baiyun; Yagoda, Sergey; Claxton, Amy (2021. ) Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study.BMC psychiatry, , 21 (1 ) ,492 More Information

Aboraya, Ahmed; Nasrallah, Henry A; Elswick, Daniel; Rastgar, Yasha; Berry, James; Hill, Cheryl; Justice, John; Zheng, Wanhong; Pearson, Nathan; Gallucci, Gerard; Figgs, Patricia; Hustead, Jeremy; Vogt, Joel; Zafar, Jawad; Dohar, Sheena; Looper, Robert; Guinan, Danielle; Elawady, Akram; Shah, Omar; Lam, Mei Wai; Shagufta, Shanila; Schwartzman, Noah; Hamric, Eddie; Mayle, Lauren; Miller, Mark; Chandran, Dilip; Marshalek, Patrick; Moreland, Rachel; Tamang, Tenchee Lama; Mattancheril, Sunny; Berzingi, Sara (2021. ) Measurement-based care training curriculum in psychiatry residency programs: I: Description of the curriculum and demonstration of implementation.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 33 (3 ) ,168-179 More Information

Nasrallah, Henry A (2021. ) Re-inventing the DSM as a transdiagnostic model: Psychiatric disorders are extensively interconnected.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 33 (3 ) ,148-150 More Information

Sagarwala, Raza; Nasrallah, Henry A (2021. ) The effect of antipsychotic medications on white matter integrity in first-episode drug-naïve patients with psychosis: A review of DTI studies.Asian journal of psychiatry, , 61 ,102688 More Information

Nasrallah, Henry A (2021. ) The pro- and con-debate about the at-risk state and early intervention: A commentary.Schizophrenia research, , 227 ,18-19 More Information

Sagarwala, Raza; Nasrallah, Henry A (2020. ) White matter pathology in patients with borderline personality disorder: A review of controlled DTI studies.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 32 (4 ) ,281-286 More Information

Sagarwala, Raza; Nasrallah, Henry A (2020. ) The effects of yoga on depression and motor function in patients with Parkinson's disease: A review of controlled studies. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 32 (3 ) ,209-215

Sagarwala, Raza; Nasrallah, Henry A (2020. ) A systematic review of diffusion tensor imaging studies in drug-naïve OCD patients before and after pharmacotherapy. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 32 (1 ) ,42-47

Sagarwala, Raza; Nasrallah, Henry A (2019. ) Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 31 (4 ) ,292-297

Douglas, Jasmine; Nasrallah, Henry A (2019. ) Low high-density lipoprotein and psychopathology: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 31 (3 ) ,209-213

Kahlon, Chanchal K; Nasrallah, Henry A (2019. ) Bidirectional relationship between transient ischemic attacks and depression: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 31 (3 ) ,214-220

Nasrallah, Henry A; Aquila, Ralph; Du, Yangchun; Stanford, Arielle D; Claxton, Amy; Weiden, Peter J (2019. ) Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia.CNS spectrums, , 24 (4 ) ,395-403 More Information

Chen, Alexander T; Nasrallah, Henry A (2019. ) Neuroprotective effects of the second generation antipsychotics.Schizophrenia research, , 208 ,1-7 More Information

Nasrallah, Henry A; Fedora, Rissa; Morton, Robert (2019. ) Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist.Schizophrenia research, , 208 ,217-220 More Information

Cannon, Cornita; Nasrallah, Henry A (2019. ) A focus on postpartum depression among African American women: A literature review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 31 (2 ) ,138-143

Aboraya, Ahmed; Nasrallah, Henry A; Elswick, Daniel E; Ahmed, Elshazly; Estephan, Nevine; Aboraya, Dalia; Berzingi, Seher; Chumbers, Josleen; Berzingi, Sara; Justice, John; Zafar, Jawad; Dohar, Sheena (2018. ) Measurement-based Care in Psychiatry-Past, Present, and Future. Innovations in clinical neuroscience, , 15 (11-12 ) ,13-26

Khoury, Rita; Nasrallah, Henry A (2018. ) Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?.Schizophrenia research, , 199 ,31-38 More Information

Lu, Syshane; Nasrallah, Henry A (2018. ) The use of memantine in neuropsychiatric disorders: An overview. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 30 (3 ) ,234-248

Chen, Alexander T; Malmstrom, Theodore; Nasrallah, Henry A (2018. ) Body temperature rises following improvement of depression with ECT. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 30 (3 ) ,196-199

Citrome, Leslie; Risinger, Robert; Cutler, Andrew J; Du, Yangchun; Zummo, Jacqueline; Nasrallah, Henry A; Silverman, Bernard L (2018. ) Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study.CNS spectrums, , 23 (4 ) ,284-290 More Information

Nasrallah, Henry A (2018. ) Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortality.Schizophrenia research, , 197 ,69-70 More Information

Sagarwala, Raza; Malmstrom, Theodore; Nasrallah, Henry A (2018. ) Effects of nonpharmacological therapies on anxiety and cortisol: A meta-analysis. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 30 (2 ) ,91-96

Adams, Selin A; Nasrallah, Henry A (2018. ) Multiple retinal anomalies in schizophrenia.Schizophrenia research, , 195 ,3-12 More Information

Durgam, Suresh; Earley, Willie; Li, Rui; Li, Dayong; Lu, Kaifeng; Laszlovszky, István; Wolfgang Fleischhacker, W; Nasrallah, Henry A (2018. ) Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271].Schizophrenia research, , 192 ,493 More Information

Chen, Alexander T; Malmstrom, Theodore; Nasrallah, Henry A (2018. ) Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials.Journal of affective disorders, , 226 ,245-250 More Information

Aboraya, Ahmed; Leucht, Stefan; Nasrallah, Henry A; Samara, Myrto; Haro, Josep Maria; Elshazly, Ahmed; Zangeneh, Masood (2017. ) A novel approach to measuring response and remission in schizophrenia in clinical trials.Schizophrenia research, , 190 ,123-128 More Information

Nasrallah, Henry A; Earley, Willie; Cutler, Andrew J; Wang, Yao; Lu, Kaifeng; Laszlovszky, István; Németh, György; Durgam, Suresh (2017. ) The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.BMC psychiatry, , 17 (1 ) ,305 More Information

Nasrallah, Henry A; Chen, Alexander T (2017. ) Multiple neurotoxic effects of haloperidol resulting in neuronal death. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 29 (3 ) ,195-202

Nasrallah, Henry A; Aquila, Ralph; Stanford, Arielle D; Jamal, Hasan H; Weiden, Peter J; Risinger, Robert (2017. ) Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil. Psychopharmacology bulletin, , 47 (3 ) ,35-43

Durgam, Suresh; Landbloom, Ronald P; Mackle, Mary; Wu, Xiao; Mathews, Maju; Nasrallah, Henry A (2017. ) Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study.Neuropsychiatric disease and treatment, , 13 ,2021-2035 More Information

Blanchard, Jack J; Bradshaw, Kristen R; Garcia, Cristina P; Nasrallah, Henry A; Harvey, Philip D; Casey, Daniel; Csoboth, Csilla T; Hudson, James I; Julian, Laura; Lentz, Ellen; Nuechterlein, Keith H; Perkins, Diana O; Skale, Tracey G; Snowden, Lonnie R; Tandon, Rajiv; Tek, Cenk; Velligan, Dawn; Vinogradov, Sophia; O'Gorman, Cedric (2017. ) Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.Schizophrenia research, , 185 ,137-143 More Information

Upadhyaya, Mihir A; Nasrallah, Henry A (2017. ) The intense desire for healthy limb amputation: A dis-proprioceptive neuropsychiatric disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 29 (2 ) ,125-132

Keshavan, Matcheri S; Lawler, Ashley N; Nasrallah, Henry A; Tandon, Rajiv (2017. ) New drug developments in psychosis: Challenges, opportunities and strategies.Progress in neurobiology, , 152 ,3-20 More Information

Keshavan, Matcheri S; DeLisi, Lynn E; Nasrallah, Henry A (2017. ) Translational and spectrum aspects of Schizophrenia Research: The rationale for new journal's new subheading.Schizophrenia research, , 179 ,1 More Information

Nasrallah, Henry A; Newcomer, John W; Risinger, Robert; Du, Yangchun; Zummo, Jacqueline; Bose, Anjana; Stankovic, Srdjan; Silverman, Bernard L; Ehrich, Elliot W (2016. ) Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia.The Journal of clinical psychiatry, , 77 (11 ) ,1519-1525 More Information

Durgam, Suresh; Earley, Willie; Li, Rui; Li, Dayong; Lu, Kaifeng; Laszlovszky, István; Fleischhacker, W Wolfgang; Nasrallah, Henry A (2016. ) Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.Schizophrenia research, , 176 (2-3 ) ,264-271 More Information

Chen, Alexander T; Chibnall, John T; Nasrallah, Henry A (2016. ) Placebo-controlled augmentation trials of the antioxidant NAC in schizophrenia: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 28 (3 ) ,190-6

Nasrallah, Henry A (2016. ) A Valedictory from the Founding Editors.Schizophrenia research, , 175 (1-3 ) ,1 More Information

Alphs, Larry; Nasrallah, Henry A; Bossie, Cynthia A; Fu, Dong-Jing; Gopal, Srihari; Hough, David; Turkoz, Ibrahim (2016. ) Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy.International clinical psychopharmacology, , 31 (4 ) ,202-9 More Information

Yum, Sun Young; Hwang, Michael Y; Nasrallah, Henry A; Opler, Lewis A (2016. ) Transcending Psychosis: The Complexity of Comorbidity in Schizophrenia.The Psychiatric clinics of North America, , 39 (2 ) ,267-74 More Information

Aboraya, Ahmed; Nasrallah, Henry A (2016. ) Perspectives on the Positive and Negative Syndrome Scale (PANSS): Use, misuse, drawbacks, and a new alternative for schizophrenia research. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 28 (2 ) ,125-31

Gondim, Francisco de Assis Aquino; Thomas, Florian P; Cruz-Flores, Salvador; Nasrallah, Henry A; Selhorst, John B (2016. ) Pathological laughter and crying: A case series and proposal for a new classification. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 28 (1 ) ,11-21

Chen, Alexander T; Chibnall, John T; Nasrallah, Henry A (2015. ) A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 27 (4 ) ,289-96

Lawson, William; Johnston, Stephen; Karson, Craig; Offord, Steve; Docherty, John; Eramo, Anna; Kamat, Siddhesh; Blanchette, Christopher M; Carson, William; Nasrallah, Henry A (2015. ) Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 27 (4 ) ,242-52

Nasrallah, Henry A (2015. ) Toward the era of transformational neuropsychiatry.Asian journal of psychiatry, , 17 ,140-1 More Information

Nasrallah, Henry A (2015. ) Consequences of misdiagnosis: inaccurate treatment and poor patient outcomes in bipolar disorder.The Journal of clinical psychiatry, , 76 (10 ) ,e1328 More Information

Serafini, Gianluca; Gonda, Xenia; Rihmer, Zoltan; Pompili, Maurizio; Girardi, Paolo; Nasrallah, Henry A; Amore, Mario (2015. ) NMDA receptor antagonists for depression: Critical considerations. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 27 (3 ) ,213-20

Meltzer, Herbert Y; Risinger, Robert; Nasrallah, Henry A; Du, Yangchun; Zummo, Jacqueline; Corey, Lisa; Bose, Anjana; Stankovic, Srdjan; Silverman, Bernard L; Ehrich, Elliot W (2015. ) A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.The Journal of clinical psychiatry, , 76 (8 ) ,1085-90 More Information

Nasrallah, Henry A; Harvey, Philip D; Casey, Daniel; Csoboth, Csilla T; Hudson, James I; Julian, Laura; Lentz, Ellen; Nuechterlein, Keith H; Perkins, Diana O; Kotowsky, Nirali; Skale, Tracey G; Snowden, Lonnie R; Tandon, Rajiv; Tek, Cenk; Velligan, Dawn; Vinogradov, Sophia; O'Gorman, Cedric (2015. ) The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization.Schizophrenia research, , 166 (1-3 ) ,69-79 More Information

Nasrallah, Henry A; Cucchiaro, Josephine B; Mao, Yongcai; Pikalov, Andrei A; Loebel, Antony D (2015. ) Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies.CNS spectrums, , 20 (2 ) ,140-7 More Information

Schooler, Nina R; Buchanan, Robert W; Laughren, Thomas; Leucht, Stefan; Nasrallah, Henry A; Potkin, Steven G; Abi-Saab, Danielle; Berardo, Carmen Galani; Bugarski-Kirola, Dragana; Blaettler, Thomas; Edgar, Chris J; Nordstroem, Anna-Lena; O'Gorman, Cedric; Garibaldi, George (2015. ) Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms.Schizophrenia research, , 162 (1-3 ) ,169-74 More Information

Park, Sohee; Nasrallah, Henry A (2014. ) The varieties of anomalous self experiences in schizophrenia: splitting of the mind at a crossroad.Schizophrenia research, , 152 (1 ) ,1-4 More Information

Ravyn, Dana; Ravyn, Vipa; Lowney, Robert; Nasrallah, Henry A (2013. ) CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.Schizophrenia research, , 149 (1-3 ) ,1-14 More Information

Keshavan, M S; Tandon, R; Nasrallah, H A (2013. ) Renaming schizophrenia: keeping up with the facts.Schizophrenia research, , 148 (1-3 ) ,1-2 More Information

McEvoy, Joseph; Baillie, Rebecca A; Zhu, Hongjie; Buckley, Peter; Keshavan, Matcheri S; Nasrallah, Henry A; Dougherty, George G; Yao, Jeffrey K; Kaddurah-Daouk, Rima (2013. ) Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics.PloS one, , 8 (7 ) ,e68717 More Information

Nasrallah, Henry A; Silva, Robert; Phillips, Debra; Cucchiaro, Josephine; Hsu, Jay; Xu, Jane; Loebel, Antony (2013. ) Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.Journal of psychiatric research, , 47 (5 ) ,670-7 More Information

Watson, A M M; Prasad, K M; Klei, L; Wood, J A; Yolken, R H; Gur, R C; Bradford, L D; Calkins, M E; Richard, J; Edwards, N; Savage, R M; Allen, T B; Kwentus, J; McEvoy, J P; Santos, A B; Wiener, H W; Go, R C P; Perry, R T; Nasrallah, H A; Gur, R E; Devlin, B; Nimgaonkar, V L (2013. ) Persistent infection with neurotropic herpes viruses and cognitive impairment.Psychological medicine, , 43 (5 ) ,1023-31 More Information

Stroup, T Scott; Byerly, Matthew J; Nasrallah, Henry A; Ray, Neepa; Khan, Ahsan Y; Lamberti, J Steven; Glick, Ira D; Steinbook, Richard M; McEvoy, Joseph P; Hamer, Robert M (2013. ) Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.Schizophrenia research, , 146 (1-3 ) ,190-5 More Information

Nasrallah, Henry A; Delisi, Lynn E (2013. ) 25 years of editing Schizophrenia research: a unique and gratifying journey.Schizophrenia research, , 143 (1 ) ,1-2 More Information

Bamne, Mikhil; Wood, Joel; Chowdari, Kodavali; Watson, Annie M; Celik, Cemil; Mansour, Hader; Klei, Lambertus; Gur, Ruben C; Bradford, L DiAnne; Calkins, Monica E; Santos, Alberto B; Edwards, Neil; Kwentus, Joseph; McEvoy, Joseph P; Allen, Trina B; Savage, Robert M; Nasrallah, Henry A; Gur, Raquel E; Perry, Rodney T; Go, Rodney C P; Devlin, Bernie; Yolken, Robert; Nimgaonkar, Vishwajit L (2012. ) Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.Schizophrenia bulletin, , 38 (6 ) ,1149-54 More Information

Kaddurah-Daouk, Rima; McEvoy, Joseph; Baillie, Rebecca; Zhu, Hongjie; K Yao, Jeffrey; Nimgaonkar, Vishwajit L; Buckley, Peter F; Keshavan, Matcheri S; Georgiades, Anastasia; Nasrallah, Henry A (2012. ) Impaired plasmalogens in patients with schizophrenia.Psychiatry research, , 198 (3 ) ,347-52 More Information

Citrome, Leslie; Nasrallah, Henry A (2012. ) On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not.Expert opinion on pharmacotherapy, , 13 (11 ) ,1599-613 More Information

Gohlke, Julia M; Dhurandhar, Emily J; Correll, Christoph U; Morrato, Elaine H; Newcomer, John W; Remington, Gary; Nasrallah, Henry A; Crystal, Stephen; Nicol, Ginger ; Allison, David B (2012. ) Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.Frontiers in psychiatry, , 3 ,62 More Information

Nasrallah, Henry A (2012. ) Does the neurotoxicity of haloperidol explain the higher mortality in dementia patients compared with the second generation agents?.The American journal of psychiatry, , 169 (6 ) ,663-4; author reply More Information

Gilday, Elizabeth; Nasrallah, Henry A (2012. ) Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia.Reviews on recent clinical trials, , 7 (1 ) ,2-9 More Information

Hudepohl, Neha S; Nasrallah, Henry A (2012. ) Antipsychotic drugs.Handbook of clinical neurology, , 106 ,657-67 More Information

Jameson, Kathryn G; Nasrallah, Henry A; Northern, Tracie G; Welge, Jeffrey A (2011. ) Executive function impairment in first-degree relatives of persons with schizophrenia: A meta-analysis of controlled studies.Asian journal of psychiatry, , 4 (2 ) ,96-9 More Information

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S (2011. ) "Just the facts": meandering in schizophrenia's many forests.Schizophrenia research, , 128 (1-3 ) ,5-6 More Information

Keshavan, Matcheri S; Nasrallah, Henry A; Tandon, Rajiv (2011. ) Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.Schizophrenia research, , 127 (1-3 ) ,3-13 More Information

Devulapalli, Kavi; Nasrallah, Henry A (2010. ) Schizophrenia and obsessive-compulsive disorder.The American journal of psychiatry, , 167 (11 ) ,1407-8 More Information

Nasrallah, Henry A; Goldberg, Joseph F; Correll, Cristoph U (2010. ) Differential diagnosis and therapeutic management of schizoaffective disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 22 (4 Suppl 1 ) ,S1-12

Nasrallah, Henry A (2010. ) Linkage of cognitive impairments with metabolic disorders in schizophrenia.The American journal of psychiatry, , 167 (10 ) ,1155-7 More Information

Devulapalli, Kavi K; Nasrallah, Henry A (2009. ) An analysis of the high psychotropic off-label use in psychiatric disorders The majority of psychiatric diagnoses have no approved drug.Asian journal of psychiatry, , 2 (1 ) ,29-36 More Information

Nasrallah, H A; Balling, R C (1995. ) Impact of desertification on temperature trends in the Middle East.Environmental monitoring and assessment, , 37 (1-3 ) ,265-71 More Information

Tripathi, Ashutosh; Nasrallah, Henry A; Pillai, Anilkumar (2023. ) Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats.Frontiers in neuroscience, , 17 ,1237726 More Information

Kwok, Wan Y; Stephens, Victoria; Nasrallah, Henry A (2023. ) High-dose armodafinil in treatment-refractory bipolar depression.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, , 35 (3 ) ,195-198 More Information

Gebhardt, Susanna; Nasrallah, Henry A (2023. ) The role of the insula in cognitive impairment of schizophrenia.Schizophrenia research. Cognition, , 32 ,100277 More Information

Nasrallah, Henry A; Keshavan, Matcheri (2023. ) Controversies and knowledge expansion in psychiatry.Asian journal of psychiatry, , 82 ,103535 More Information

Nasrallah, Henry A (2023. ) Is preventing the second psychotic episode a disease-modifying strategy for schizophrenia?.Schizophrenia research, , 252 ,326-328 More Information

Goldberg, Joseph F; Nasrallah, Henry A (2022. ) Major depression is a serious and potentially fatal brain syndrome requiring pharmacotherapy or neuromodulation, and psychotherapy.Psychological medicine, , 52 (8 ) ,1423-1425 More Information

Serafini, Gianluca; Nasrallah, Henry A; Amore, Mario (2022. ) The use of modern dopamine partial agonists in bipolar depression: is the evidence sound?.Current medical research and opinion, , 38 (5 ) ,773-775 More Information

Nasrallah, Henry A (2022. ) Re-inventing the schizophrenia syndrome: The elusive "theory of everything".Schizophrenia research, , 242 ,106-108 More Information

Nocera, Annamarie; Nasrallah, Henry A (2022. ) The Association of the Gut Microbiota with Clinical Features in Schizophrenia.Behavioral sciences (Basel, Switzerland), , 12 (4 ) , More Information

Nasrallah, Henry A (2021. ) To change the label of schizophrenia, first revise the construct.Schizophrenia research, , 238 ,201-202 More Information

Nervous System(MeSH A08),Nervous System Diseases(MeSH C10),Neurotransmitters and Neurotransmitter Agents(MeSH D14),Mental Disorders(MeSH F03),Health Occupations(MeSH G02)

Henry Nasrallah, MD, is a physician with University of Cincinnati Physicians.

Practice Location:
UC Health Psychiatry (Stetson Building)
260 Stetson Street, Suite 3200
Cincinnati, Ohio 45219

Clinical Specialties:
Psychiatry/Psychology, Psychotic Disorders

To make an appointment, please call (513) 475-8000.

 

Academic - Stetson Building
Suite 3200
Cincinnati  Ohio, 45219
Phone: 513-558-7700
henry.nasrallah@uc.edu